Latest News - Cataract Surgery

Thursday, August 24, 2017 | Cataract Surgery, Product Releases

Coburn Technologies Introduces New Cobalt Lens Generators, Cobalt NXT & NXT+

Coburn Technologies has introduced its newest lens generators -- the Cobalt NXT & NXT+. The Cobalt NXT is the successor to Coburn’s current large-format freeform generator, the Cobalt DS. To…

Read the full story

Tuesday, August 01, 2017 | Cataract Surgery

Mynosys Cellular Devices Receives $1 Million NEI Grant to Commercialize the Zepto Capsulotomy System

Mynosys Cellular Devices announced that it has received a SB1 Commercialization Readiness Program (CRP) Award from the National Eye Institute of the National Institutes of Health. CRP is administered …

Read the full story

Monday, July 31, 2017 | Cataract Surgery

FDA Warns About Triamcinolone and Moxifloxacin Combo for Eye

FDA issued a safety alert after receiving adverse event reports concerning at least 43 patients who were administered intravitreal injections of a drug containing triamcinolone and moxifloxacin compou…

Read the full story

Thursday, July 27, 2017 | Cataract Surgery, Medical Studies

Steady Growth in Cataract Surgical Procedures Is Expected Over the Next 5 Years

Market Scope forecasts that the cataract surgical equipment market will grow at a compound annual growth rate (CAGR) of 5.6 percent a year, totaling $2 billion by 2022. Cataracts are a leading caus…

Read the full story

Friday, July 07, 2017 | Cataract Surgery, Medical Studies

Report: Patients Forced to Beg NHS to Fund Cataract or Hip Surgery

Patients are having to plead with the National Health Service (NHS) in England for hip replacements, cataract surgery, and other routine treatments that were once provided without question, an investi…

Read the full story

Monday, June 26, 2017 | Cataract Surgery, Clinical Trials

Icon Bioscience Annouces FDA Acceptance of NDA Filing for DEXYCU, a Noval Drug Therapy for Treating Inflammation Associated with Cataract Surgery

Icon Bioscience announced that it has received notification from the FDA that the agency has accepted for filing the company’s recently submitted new drug application (NDA) for DEXYCU (IBI-10090…

Read the full story

Wednesday, April 19, 2017 | Cataract Surgery, Partnerships, Carl Zeiss Meditec

First SMILE Laser Eye Surgery Procedures for US Navy Performed at Naval Medical Center San Diego

The first Zeiss ReLEx SMILE procedures for US Navy personnel were performed by Cmdr. John B. Cason, MD, Program Director, Navy Refractive Surgery Center San Diego. These procedures for the US Navy fol…

Read the full story

Monday, March 20, 2017 | Cataract Surgery, Medical Studies, Imprimis Pharmaceuticals

Peer-Reviewed Paper Demonstrates the Benefits of Dropless Cataract Surgery

Imprimis Pharmaceuticals, an ophthalmology-focused pharmaceutical company, today announced the publication of a dropless therapy article in the peer-reviewed journal, Current Pharmaceutical Desig…

Read the full story

Wednesday, February 22, 2017 | Cataract Surgery, Ocular Therapeutix

Ocular Therapeutix Announces FDA Acceptance of NDA Resubmission for Dextenza for the Treatment of Ocular Pain After Ophthalmic Surgery

Ocular Therapeutix announced that the company’s new drug application (NDA) resubmission for Dextenza (dexamethasone insert) 0.4 mg for intracanalicular use for the treatment of ocular pain occur…

Read the full story

Wednesday, January 04, 2017 | Cataract Surgery, Clinical Trials, Ocular Therapeutix

Ocular Therapeutix Announces Additional Successful Results for Phase 3 Clinical Trial of Dextenza

Ocular Therapeutix announced additional positive secondary endpoint results from its most recent successful phase 3 clinical trial of Dextenza (dexamethasone insert) 0.4 mg for the treatment of postsu…

Read the full story

Friday, December 02, 2016 | Cataract Surgery

Update on Zepto, The Disposable Capsulotomy Device

In this interview from AAO 2016, Dr. David Chang discusses his experience with Zepto (Mynosys Inc., Fremont, CA), an inexpensive and disposable capsulotomy device that uses low-energy pulses to create…

Read the full story

Friday, July 22, 2016 | Cataract Surgery, Medical Studies, Imprimis Pharmaceuticals

Peer-Reviewed Study of Dropless Cataract Surgery Shows 'Measurable Benefits' Compared to Drops

Imprimis Pharmaceuticals announced that positive results of a clinical study comparing the efficacy of its injected triamcinolone acetonide, moxifloxacin hydrochloride, and vancomycin (Tri-Moxi-Vanc) …

Read the full story

Monday, July 11, 2016 | Cataract Surgery, Health Care

Health Tourists Jump Queue for Cataract Operations on NHS as British Patients Wait up to 8 Months

Health tourists are being given cataract surgery on the NHS ahead of British patients because their conditions are considered more of a priority, it has emerged. Hundreds of people from countries incl…

Read the full story

Wednesday, June 29, 2016 | Cataract Surgery, Partnerships

Harman and HelpMeSee Partner to Reduce Blindness on a Global Scale

Harman announced its role in developing an enterprise software solution for simulation-based training management with HelpMeSee, the global campaign to end cataract blindness. This Training Management…

Read the full story

Wednesday, June 01, 2016 | Cataract Surgery, Clinical Trials, Eyegate Pharmaceuticals

EyeGate Announces Interim Data from Clinical Trial of EGP-437 for Treatment of Inflammation and Pain After Cataract Surgery

EyeGate Pharmaceuticals announced interim data from its phase 1b/2a trial evaluating its lead product candidate, iontophoretic EGP-437, in the treatment of ocular inflammation and pain in cataract sur…

Read the full story
Load More